OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

2.19
Delayed Data
As of Apr 24
 +0.04 / +1.86%
Today’s Change
1.92
Today|||52-Week Range
10.60
-4.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues11.7M4.9M4.8M5.7M
 
 
 
 
 
Depreciation And Amortization55.0K55.0K55.0K58.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses19.6M12.5M12.0M12.5M
 
 
 
 
 
Research And Development16.9M9.9M9.6M9.9M
 
 
 
 
 
Total Operating Expenses19.7M12.6M12.0M12.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.9M-7.6M-7.2M-6.9M
 
 
 
 
 
Extraordinary Credit0.00615.0K2.9M267.0K
 
 
 
 
Extraordinary Charge-721.0K0.00-531.0K--
 
 
 
Other Expenses2.0K-4.0K-11.0K967.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.6M-7.0M-4.9M-5.7M
 
 
 
 
 
Net Income-8.6M-7.0M-4.9M-5.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.7M15.0M21.1M21.5M
 
 
 
 
 
Shares To Calculate EPS Diluted14.7M15.0M21.1M21.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.59-$0.47-$0.23-$0.26
 
 
 
 
 
EPS Diluted-$0.59-$0.47-$0.23-$0.26
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account